Explore the ever-evolving world of cancer care in our insightful content series, Labcorp Perspectives as we delve into the latest advancements in oncology diagnostics and their impact on patient outcomes. Each episode brings together leading oncology experts to discuss:
• Groundbreaking research: Uncovering the cutting-edge science shaping the future of cancer treatment
• Practical applications: Learning how precision medicine translates from lab to the clinic
• Real-world challenges: Exploring the hurdles faced in oncology care and discovering potential solutions
More than just information, this series fosters collaboration and unbiased education. Labcorp Perspectives not only empowers healthcare professionals and researchers but also patients to stay informed, inspired and at the forefront of medical oncology.
All content for Labcorp Perspectives: Oncology is the property of Labcorp and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Explore the ever-evolving world of cancer care in our insightful content series, Labcorp Perspectives as we delve into the latest advancements in oncology diagnostics and their impact on patient outcomes. Each episode brings together leading oncology experts to discuss:
• Groundbreaking research: Uncovering the cutting-edge science shaping the future of cancer treatment
• Practical applications: Learning how precision medicine translates from lab to the clinic
• Real-world challenges: Exploring the hurdles faced in oncology care and discovering potential solutions
More than just information, this series fosters collaboration and unbiased education. Labcorp Perspectives not only empowers healthcare professionals and researchers but also patients to stay informed, inspired and at the forefront of medical oncology.
Tumor-Agnostic Therapies and the Future of HER2 in Oncology
Labcorp Perspectives: Oncology
20 minutes 35 seconds
4 months ago
Tumor-Agnostic Therapies and the Future of HER2 in Oncology
What tumor-agnostic approvals mean for HER2, NGS, and precision oncology — and how they’re changing treatment across cancer types.
Labcorp Perspectives: Oncology
Explore the ever-evolving world of cancer care in our insightful content series, Labcorp Perspectives as we delve into the latest advancements in oncology diagnostics and their impact on patient outcomes. Each episode brings together leading oncology experts to discuss:
• Groundbreaking research: Uncovering the cutting-edge science shaping the future of cancer treatment
• Practical applications: Learning how precision medicine translates from lab to the clinic
• Real-world challenges: Exploring the hurdles faced in oncology care and discovering potential solutions
More than just information, this series fosters collaboration and unbiased education. Labcorp Perspectives not only empowers healthcare professionals and researchers but also patients to stay informed, inspired and at the forefront of medical oncology.
